Cambridge Health Alliance is a healthcare provider in Cambridge, Somerville and Boston's metro-north communities in Massachusetts. CHA offers services including primary care, specialty care, and mental health/substance use services.

During the past decade, Cambridge Health Alliance conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cambridge Health Alliance" #1 sponsor was "Cambridge Health Alliance" with 16 trials, followed by "Massachusetts General Hospital" with 4 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored, "Boston University Charles River Campus" with 1 trials sponsored and "Euthymics BioScience, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cambridge Health Alliance" #1 collaborator was "Cambridge Health Alliance" with 4 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Otsuka America Pharmaceutical" with 2 trials as a collaborator and "Psychiatric Medicine Associates, L.L.C." with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Cambridge Health Alliance" are "Bipolar Disorder" (7 trials), "Major Depressive Disorder" (3 trials), "Autistic Disorder" (2 trials), "Behavioral Symptoms" (2 trials) and "Depression" (2 trials). Many other conditions were trialed in "Cambridge Health Alliance" in a lesser frequency.

Most popular intervention types in "Cambridge Health Alliance" are "Drug" (16 trials), "Behavioral" (7 trials), "Other" (5 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aripiprazole" (4 trials), "Placebo" (3 trials), "24 Month PPCM BP" (1 trials), "9 Month PPCM BP" (1 trials) and "CHAMindWell" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cambridge Health Alliance" are 29 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cambridge Health Alliance". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Cambridge Health Alliance, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cambridge Health Alliance, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 12 trials that are defined as “Not Applicable".

Cambridge Health Alliance has several departments that took part in Clinical trials: "Cambridge Pediatrics" - 2 trials